IFRScommunity.com

yes. presumably the lessor novated the lease to another party.

nothing

Why are you changing it

substance is it's an extension, even if technically a new lease

lease modification - remeasure liability using revised discount rate and revise asset accordingly

I guess the other option for the Debit is to increase the investment in associate by your share as a capital contribution (like if it was a subsidiary) but I don't know the answer I'm afraid!

previous year audited by KPMG...

if the link doesn't work for you (does for me) go to https://find-and-update.company-informa ... ce.gov.uk/ and look at the 2022 accounts of The University of Law Limited

Check this out... a nightmare one https://s3.eu-west-2.amazonaws.com/document-api-images-live.ch.gov.uk/docs/d6LJMz3OQF4S7AwDdznX-7CJbFIAS5S54vgTooQU2og/application-pdf?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=ASIAWRGBDBV3LFT6LLX3%2F20240408%2Feu-west-2%2Fs3%2Faws4_request&X-Amz-Dat...

If you knew you had achieved the volume for a discount and the invoices received were pre-discount, I'd recognise the discount in P&L with a corresponding adjustment to payables and then offset it when the credit note was subsequently received

can you demonstrate your ability to accurately forecast 7 years ahead, based on a review of previous forecasts made? (ias 36 para 35)

yes

Use the first 5 years from your forecast then apply the terminal value if it's appropriate to assume the asset will be valuable for ever....
The idea is that you can't reasonably forecast over 5 years so you can only assume the wider market growth rate after that

the latter could be an asset under IFRS 15; it will depend a lot on the specifics if you have a specific case to share

Are you an (unhappy) auditor? This is the same reason you would review post year end credit notes in revenue testing.

Most likely represents conditions at year end, eg incorrect pricing or volume etc, so is an adjusting event. Or is it because of decisions made/arising entirely after year end?

Interested to hear where you are with it currently ConfussedA. Do you think it's a genuine sale in substance?

if your business is only doing export business then maybe perform the reconciliation against 3%. you don't have to use the headline rate in your country. if it's a mix then a reconciling item might be the effect of reduced rate on export profits. for deferred tax, same question really...what are you...

so the estimate of useful life may have been wrong in the first place then.

but anyway, once it's fully depreciated you can't bring the value back unless you think there was an error to restate.

or have you overhauled the asset so that it has a new cost to depreciate?

is it because of an error in earlier periods, or new information about the useful life?

Leo, maybe the subsidiary has net liabilities which is why the existing shareholders would be happy to be diluted in this way.

PS are the (now) minority shareholders happy with this arrangement!

It's an interesting question, since the cash never leaves the group. So the group isn't acquiring that cash.

Seems like a restructuring provision (with disclosure) will do the trick. Presumably this is one element of various costs to be incurred as part of that restructuring. IAS 19 scope says it includes items where an obligation arises and where there is no realistic alternative but to pay the benefit. W...

Jackob, good point about bullet loans, maybe there's 1 day left but actually there is no record of payments being made, as none were due until the last day. I guess that makes monitoring much more complex as you have no observable information. I guess you obtain even more evidence in these cases, eg...

If you're asking whether it's acceptable to show the interest within finance costs, yes, I think you've identified the para which requires that.

Depends on the wording in the loan agreement as to the contractual period over which interest accrues. But if it's contractually due, then the bad debt is the entire amount including accrued interest.

Are you writing off, or raising a 100% credit loss provision?

If you isolate R&D costs as a separate P&L line perhaps you're better to put the RoU asset depreciation there?

write back through P&L, effectively as a change in measurement of contingent consideration

statement of changes in equity.

are you referring to the share based payment charge within P&L? (ie the debit rather than the credit)? if so, add it back as a non-cash movement.